Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient vs HCP Managed Titration of Insulin Glulisine in T2DM
NCT01013571Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2009
- Primary completion
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Oct 2009; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01013571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013571.